Q2 2019 Holdings
Filed 2019-08-13 | 163 holdings | $200.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $126.6M | 1,099,824 | 63.2% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $46.3M | 2,093,221 | 23.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $7.3M | 84,896 | 3.6% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $4.2M | 1,911,573 | 2.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COMM | 004225108 | $4.2M | 155,576 | 2.1% |
| Akebia Therapeutics Inc(AKBA) | COMM | 00972D105 | $4.1M | 848,356 | 2.0% |
| AbbVie Inc(ABBV) | COMM | 00287Y109 | $2.1M | 28,911 | 1.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COMM | 02043Q107 | $2.0M | 27,792 | 1.0% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $1.6M | 426,400 | 0.8% |
| Autolus Therapeutics PLC(AUTL) | ADR | 05280R100 | $1.1M | 65,780 | 0.5% |
| Amarin | ADR | 023111206 | $101.0K | 5,208,305 | 0.1% |
| Natera(NTRA) | COMM | 632307104 | $85.5K | 3,100,560 | 0.0% |
| Principia Biopharma(PRNB) | COMM | 74257L108 | $67.6K | 2,038,208 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $53.7K | 4,749,623 | 0.0% |
| Spark Therapeutics | COMM | 84652J103 | $49.3K | 481,270 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $48.1K | 2,104,278 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $37.8K | 2,521,856 | 0.0% |
| Audentes Therapeutics(BOLDEUR) | COMM | 05070R104 | $35.3K | 933,640 | 0.0% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $34.6K | 1,729,352 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $28.7K | 1,961,039 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | $24.9K | 2,400,000 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $23.5K | 2,266,666 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $16.6K | 368,903 | 0.0% |
| Novo Nordisk A/S(NVO) | ADR | 670100205 | $16.5K | 323,697 | 0.0% |
| Allergan plc | COMM | G0177J108 | $14.1K | 84,433 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COMM | 64125C109 | $13.2K | 155,860 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | $12.5K | 922,700 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $12.2K | 1,630,221 | 0.0% |
| Iterum Therapeutics | COMM | G6333L101 | $11.9K | 1,726,514 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COMM | 40637H109 | $11.9K | 690,199 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COMM | 427746102 | $11.5K | 617,185 | 0.0% |
| TG Therapeutics Inc(TGTX) | COMM | 88322Q108 | $10.9K | 1,261,384 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $10.9K | 115,536 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $9.9K | 241,043 | 0.0% |
| MacroGenics Inc(MGNX) | COMM | 556099109 | $9.3K | 550,443 | 0.0% |
| MorphoSys AG | COMM | D55040105 | $9.2K | 96,135 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMM | 92532F100 | $9.2K | 50,301 | 0.0% |
| Amgen IncPut | COMM | 031162950 | $9.2K | 50,000 | 0.0% |
| Allergan plcCall | COMM | G0177J908 | $8.4K | 50,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COMM | 110122108 | $7.9K | 173,849 | 0.0% |
| Entasis Therapeutics Holdings Inc. | COMM | 293614103 | $7.6K | 1,180,178 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COMM | 03152W109 | $7.3K | 583,309 | 0.0% |
| Dermira Inc(DERMEUR) | COMM | 24983L104 | $6.3K | 659,882 | 0.0% |
| Incyte Corp(INCY) | COMM | 45337C102 | $5.9K | 69,612 | 0.0% |
| Synlogic Inc. | COMM | 87166L100 | $5.2K | 574,972 | 0.0% |
| Orchard Therapeutics PLC | ADR | 68570P101 | $5.1K | 365,469 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $4.5K | 2,204,202 | 0.0% |
| Bristol-Myers Squibb CoCall | COMM | 110122908 | $4.5K | 100,000 | 0.0% |
| Zymeworks Inc | COMM | 98985W102 | $4.1K | 188,057 | 0.0% |
| Uniqure NV(QURE)Call | COMM | N90064101 | $3.9K | 50,000 | 0.0% |